AstraZeneca today announced it has entered into a settlement agreement in its Nexium patent infringement litigation against Ranbaxy Laboratories Ltd. and its affiliates ("Ranbaxy"). The agreement s
read more » Discuss Add this link to...Bury Add to:
| Bookmarks